Loading...
Roche Holding AG
ROP.SW•SIX
Healthcare
Drug Manufacturers - General
CHF-0.30(-0.09%)
Swiss Market opens in 25h 38mRoche Holding AG (ROP.SW) AI-Powered Stock Analysis
See how Roche Holding AG scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerRoche Holding AG (ROP.SW) Stock Overall Grade
Roche Holding AG’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Roche Holding AG's overall stock rating.
Forecast
C+Score
50/100Financial Growth
CScore
40/100Fundamental Growth
AScore
89/100Key Ratios
AScore
87/100Sector Comparison
C+Score
50/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
96/100Analyst Consensus
C+Score
50/100Roche Holding AG (ROP.SW) AI-Powered Stock Analysis
This asset demonstrates Good performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (89/100, A) highlight its stability, while Key Ratios (87/100, A) and Sector Comparison (50/100, C+) indicate weak positioning. Compared to broader benchmarks like the S&P 500 (96/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests Low divergence in outlook.Component Analysis Explained
Understand the key factors behind each Roche Holding AG stock grade, including financials, comparisons, and forecasts.